Skip to main content
. 2022 Nov 15;194:110157. doi: 10.1016/j.diabres.2022.110157

Table 2D.

Demographics of the PCOS cohort with ondansetron comparator * Native Hawaiian or Other Pacific Islander.

All patients On Ondansentron On Metformin p-value
n 501 309 192
DEMOGRAPHICS
age 32.54 (8.95) 32.63 (9.21) 32.39 (8.52) 0.762
BMI 37.94 (9.39) 37.87 (9.60) 38.04 (9.13) 0.862
length of stay 5.45 (53.44) 6.94 (67.02) 3.04 (15.00) 0.427
INPATIENT/OUTPATIENT
Inpatient or ED 229 (45.7%) 195 (63.1%) 34 (17.7%) 0
RACE 0.561
White 331 (66.1%) 210 (68.0%) 121 (63.0%)
Black or African American 76 (15.2%) 49 (15.9%) 27 (14.1%)
Asian < 20 < 20 < 20
Other < 20 < 20 < 20
NHOPI* < 20 < 20 < 20
ETHNICITY 0.224
Hispanic or Latino 100 (22.6%) 55 (20.4%) 45 (25.9%)
Not Hispanic or Latino 401 (87.4%) 214 (79.6%) 129 (74.1%)
CCI > 1 75 (15.0%) > 20 < 20 0.001
Current or former smoker 96 (19.2%) 50 (16.2%) 46 (24.0%) 0.042
HOSPITAL EVENTS
AKI in hospital < 20 < 20 0 0.286
Invasive ventilation 0 0 0
ECMO < 20 < 20 0 0.698
COMORBIDITIES
prediabetes 121 (24.2%) 56 (18.1%) 65 (33.9%) 0
neoplasm 118 (23.6%) 85 (27.5%) 33 (17.2%) 0.011
hypertension 117 (23.4%) 85 (27.5%) 32 (16.7%) 0.007
chronic respiratory disease 101 (20.2%) 71 (23.0%) 30 (15.6%) 0.06
heart disease 60 (12.0%) > 20 < 20 0
liver disease 45 (9.0%) > 20 < 20 0.001
nicotine dependence 41 (8.2%) > 20 < 20 0.037